Pharma mutual funds: Kotak Healthcare leads 1-year returns at over 28% — here’s how others performed

Pharma and healthcare mutual funds have delivered positive returns over the last 1 year, but performance has varied sharply across schemes. While some active funds have gained more than 25%, several others have posted much lower returns.